NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









JelikaLite

JelikaLite

Private
New York City, New YorkHealthcare & Life Scienceshttps://jelikalite.com/

Last Round

Grant

Apr 28, 2026

Est. Valuation

$11.05M

Total Funding Raised

$2.84M

Company Overview

JelikaLite is a medical technology company that develops non-invasive neuromodulation wearable devices and AI platforms to improve symptoms in children with autism spectrum disorder.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Medical AI, Mental Health

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

neuromodulationphotobiomodulationautism treatmentwearable medical devicedigital healthpediatric medical deviceASD therapybrain health techhome-based therapymedical AIbiohackinghealthtechmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

JelikaLite Comparables

Compare JelikaLite with similar companies based on industry and business-model similarity.

JelikaLite comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Niraxx Light Therapeutics
83%
Neuronic
75%
Vielight Inc.
73%

JelikaLite Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 28, 2026
GrantSep 9, 2024
GrantApr 1, 2023
AcceleratorFeb 1, 2023
SeedFeb 1, 2023
Grant
Apr 28, 2022

Key People

Founding team and executive leadership

Katya Sverdlov

Co-Founder and CEO

Founding Team

Luis De Taboada

Chief Technology Officer

Executive Team

Liza Logounova

Chief Operating Officer

Executive Team

JelikaLite Investors

Notable investors and investment history

JelikaLite investors
InvestorRounds
Elementa LabsAccelerator
FuzeHubGrant
New York VenturesSeed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    Monthly visitors increased 75% MoM.

  • Apr 1, 2023

    $50K grant received from FuzeHub.

JelikaLite Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

JelikaLite Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about JelikaLite's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2019
Last FundingApr 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.